1158313

Pfizer, Inc. — FEI 1211022

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 19, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Groton, CT (United States)